Approaches to Assessing the Quality of Observational Studies of Clinical Practice Based on the Big Data Analysis

Por S. R. Gilyarevsky
Publicado em 2021-09-01

COMMENTS TO THE GUIDELINES

Por S. R. Gilyarevsky
Publicado em 2016-01-01

WHETHER THE STUDY ON EFFICACY OF ROSUVASTATIN IN ELDERLY PATIENTS WITH HEART FAILURE AND SYSTOLIC DYSFUNCTION OF LEFT VENTRICLE HAD BEEN COMPLETED WITH “CROWNING”?

Por S. R. Gilyarevsky
Publicado em 2015-12-01

RESULTS AND COMMENTS ON ADVANCE STUDY

Por S. R. Gilyarevsky
Publicado em 2015-12-01

Nitrate role in cardiovascular disease management: scientific evidence and clinical practice

Por S. R. Gilyarevsky
Publicado em 2007-06-01

Influence of standard heart failure therapy on readmission rate: opportunities and limitations in modern clinical practice

Por S. R. Gilyarevsky
Publicado em 2021-11-01

EFFICACY AND SAFETY OF ACCELERATED DIAGNOSTIC PROTOCOL USE IN PATIENTS WITH SUSPECTED ACUTE CORONARY SYNDROME

Por O. V. Baturina, S. R. Gilyarevsky
Publicado em 2015-09-01

Evidence-based approaches to comparing the effectiveness of modern cardiology interventions: trends, bias and prospects

Por S. R. Gilyarevsky, Yu. N. Belenkov
Publicado em 2020-09-01

THERAPEUTIC EFFECT ON HEART RATE: VISIBLE SIMPLICITY AND REAL DIFFICULTY

Por S. R. GILYAREVSKY, M. V. GOLSHMID, I. M. KUZMINA
Publicado em 2016-12-01

Retrospective analysis of electronic health records of patients with heart failure: the first Russian experience

Por S. R. Gilyarevsky, D. V. Gavrilov, A. V. Gusev
Publicado em 2021-06-01

APPROACHES TO SELECTION OF ANTIHYPERTENSION DRUG WITHIN APPLIED LOWER TARGET BLOOD PRESSURE LEVELS

Por S. R. Gilyarevsky, М. V. Golshmid, I. М. Kuzmina
Publicado em 2017-12-01

Evidence, Guidelines and Treatment Algorithms for Patients with Arterial Hypertension and Dyslipidemia: the Need for Compromise and Optimization of Tactics in Practical Healthcare

Por O. M. Drapkina, M. V. Ezhov, S. R. Gilyarevsky, R. N Shepel
Publicado em 2019-09-01

New clinical and pharmacological aspects of the use of atorvastatin for primary and secondary prevention of complications of cardiovascular diseases

Por S. R. Gilyarevsky, M. V. Golshmid, I. M. Kuzmina, I. I. Sinitsina
Publicado em 2018-09-01

Not fully informed possibilities for prevention of atherosclerosis

Por S. R. Gilyarevsky, M. V. Golshmid, I. M. Kuzmina, N. G. Bendiliani
Publicado em 2018-04-01

Adverse effects of ACE inhibitors and cardiovascular treatment tactics

Por V. A. Orlov, S. R. Gilyarevsky, D. M. Urusbieva, L. V. Daurbekova
Publicado em 2005-06-01

Anemia in Patients with Heart Failure: Current State of the Problem

Por S. R. Gilyarevsky, M. V. Golshmid, I. M. Kuzmina, N. G. Bendeliani
Publicado em 2019-04-01

Angiotensin-converting enzyme inhibitors or sartans in patients at high risk for cardiovascular events: a wrong question or an undesirable answer

Por S R Gilyarevsky, V A Orlov, I M Kuzmina, M V Golshmid
Publicado em 2013-03-01

Development of neurogenic stress cardiomyopathy after fourth ventricle tumor surgery

Por D. A. Doroshenko, S. V. Efremenko, Yu. G. Shvydkoy, E. Yu. Antonik, S. R. Gilyarevsky
Publicado em 2014-07-01

Autonomous regulation of cardiovascular system in healthy people and patients with Stage I arterial hypertension

Por S. R. Gilyarevsky, I. G. Andreeva, N. V. Balashova, V. P. Pronina, S. I. Fedorova
Publicado em 2008-06-01

THE DEVELOPMENT OF ACUTE MYOCARDIAL INFARCTION DUE TO COMPRESSION OF THE LEFT CORONARY ARTERY TRUNK BY THE CARDIAC TUMOR

Por I. M. Kuzmina, T. R. Gvindzhiliya, A. M. Shklyarov, S. R. Gilyarevsky, A. V. Chursin
Publicado em 2018-04-01